Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers
Article in The Oncologist (April 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in The Oncologist (April 2023)
Book chapter (January 2022)
Article in Head & Neck (October 2019)